We are live on ! Find out more
AIM

Achmea Investment Management Portfolio holdings

AUM $4B
1-Year Est. Return 31.99%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+31.99%
3 Year Est. Return
+113.82%
5 Year Est. Return
+148.81%
10 Year Est. Return
–
AUM
$2.83B
AUM Growth
-$267M
Cap. Flow
-$146M
Cap. Flow %
-5.17%
Top 10 Hldgs %
23.51%
Holding
675
New
40
Increased
132
Reduced
250
Closed
28

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$32.6M
2
WDAY icon
Workday
WDAY
+$17.9M
3
ADBE icon
Adobe
ADBE
+$10.1M
4
AMD icon
Advanced Micro Devices
AMD
+$7.37M
5
T icon
AT&T
T
+$7.28M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.6M
2
MSFT icon
Microsoft
MSFT
+$16M
3
TGT icon
Target
TGT
+$11.5M
4
TT icon
Trane Technologies
TT
+$10.3M
5
FERG icon
Ferguson
FERG
+$8.83M

Sector Composition

Rank Sector Weight
1 Technology 28.92%
2 Healthcare 18.36%
3 Financials 11.49%
4 Consumer Discretionary 10.21%
5 Industrials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABMD
451
DELISTED
Abiomed Inc
ABMD
$661K 0.02%
+2,692
New +$727K
L icon
452
Loews
L
$23.2B
$642K 0.02%
12,884
– –
TECH icon
453
Bio-Techne
TECH
$11.3B
$641K 0.02%
9,028
– –
AER icon
454
AerCap
AER
$23.7B
$631K 0.02%
14,904
– –
GPN icon
455
Global Payments
GPN
$22.7B
$631K 0.02%
5,841
-7,497
-56% -$925K
APO icon
456
Apollo Global Management
APO
$81.9B
$625K 0.02%
13,433
-82,392
-86% -$4.53M
LYV icon
457
Live Nation Entertainment
LYV
$43B
$611K 0.02%
8,039
– –
NBIX icon
458
Neurocrine Biosciences
NBIX
$15.9B
$609K 0.02%
5,738
+5,539
+2,783% +$562K
SIRI icon
459
SiriusXM
SIRI
$9.55B
$609K 0.02%
10,672
– –
SNOW icon
460
Snowflake
SNOW
$116B
$602K 0.02%
3,545
+3,247
+1,090% +$538K
ZBH icon
461
Zimmer Biomet
ZBH
$18.4B
$602K 0.02%
+5,762
New +$632K
REG icon
462
Regency Centers
REG
$13.9B
$597K 0.02%
11,074
– –
ROP icon
463
Roper Technologies
ROP
$38.8B
$592K 0.02%
1,646
– –
TEVA icon
464
Teva Pharmaceuticals
TEVA
$42.6B
$591K 0.02%
73,252
– –
NLY icon
465
Annaly Capital Management
NLY
$17.6B
$590K 0.02%
34,341
+861
+3% +$21.7K
PLTR icon
466
Palantir
PLTR
$414B
$586K 0.02%
72,025
– –
ACGL icon
467
Arch Capital
ACGL
$33.5B
$576K 0.02%
12,655
-40,797
-76% -$1.84M
AJG icon
468
Arthur J. Gallagher & Co
AJG
$65.4B
$570K 0.02%
3,328
+3,131
+1,589% +$556K
HST icon
469
Host Hotels & Resorts
HST
$15.6B
$556K 0.02%
35,071
+34,105
+3,531% +$594K
MAA icon
470
Mid-America Apartment Communities
MAA
$15.4B
$553K 0.02%
3,564
– –
ROK icon
471
Rockwell Automation
ROK
$50B
$547K 0.02%
2,542
– –
TWLO icon
472
Twilio
TWLO
$37.7B
$544K 0.02%
7,863
– –
PARA
473
DELISTED
Paramount Global Class B
PARA
$541K 0.02%
28,413
– –
GTM
474
ZoomInfo Technologies
GTM
$1.12B
$541K 0.02%
+12,974
New +$551K
HEI.A icon
475
HEICO Corp Class A
HEI.A
$37.7B
$539K 0.02%
4,700
– –
17 18
19
20 21

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return

Achmea Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Achmea Investment Management held 675 positions worth $2.83B, down 8.6% from $3.09B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Achmea Investment Management withdrew a net $146M in Q3 2022, closing 28 positions and reducing 250 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $7.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Achmea Investment Management opened a new position in AbbVie worth $30.5M.

  • Achmea Investment Management's largest Q3 2022 buy was AbbVie: 227,376 shares worth $30.5M.
  • Achmea Investment Management added most to Synopsys in Q3 2022, an estimated $5.91M increase.
  • Achmea Investment Management's biggest Q3 2022 reduction was Apple, cutting an estimated $16.6M.
  • Achmea Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q3 2022, selling an estimated $7.81M.
  • Achmea Investment Management's ten largest holdings make up 24% of its $2.83B portfolio in Q3 2022.
  • Achmea Investment Management opened 40 new positions and closed 28 in Q3 2022.
  • Achmea Investment Management's portfolio value fell 8.6% quarter-over-quarter to $2.83B.

Based on Achmea Investment Management's 13F filing for Q3 2022, filed 27 Oct 2022.